홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
LPCN
#4695
Lipocine Inc.
2.560
0
USD
+1.19%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.19%
월간 변동
-65.12%
6달 변화
-11.72%
년간 변동율
-11.72%
이전 종가
2.530
0
Open
2.560
0
Bid
Ask
Low
2.560
0
High
2.560
0
양
6
마켓
주식
헬스케어
LPCN
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
5.35 M
5.35 M
5.42 M
5.55 M
7.3 M
—
Valuation ratios
Enterprise value
19.9 M
13.66 M
11.08 M
11.92 M
53.41 M
90.07 M
Price to earnings ratio
—
-3.12
-3.63
-2.79
-4.75
-14.3
Price to sales ratio
2.36
4.69
4.06
3.57
23.19
35.51
Price to cash flow ratio
-21.67
-3.02
-3.37
-2.97
-4.7
-14.07
Price to book ratio
1.26
0.21
0.22
0.21
3.17
3.81
EBITDA 비율에 대한 기업 가치
-10.99
-1.95
-1.86
-1.82
-5.09
-10.71
Profitability ratios
Return on assets %
0.08
-0.09
-0.12
-0.2
-0.14
-0.55
Return on equity %
0.08
-0.1
-0.13
-0.23
-0.16
-0.61
Return on invested capital %
1 749.28
-1 668.85
-1 982.14
-2 859.92
-2 209.09
-8 719.99
Gross margin %
100
100
100
100
100
400
Operating margin %
44.27
-2 226.82
-386.03
-2 933.51
-219.65
-5 766
EBITDA margin %
40.87
-2 288.84
-391.55
-2 963.11
-225.44
-5 868.94
Net margin %
51.04
-1 986.78
-354.13
-2 781.46
-206.92
-5 329.3
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.75
15.64
12.71
8.25
6.68
43.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.16
0
0.03
0.01
0.07
0.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.31
-0.37
-0.35
-0.55
-0.51
-1.78
EBIT per share
0.29
-0.39
-0.45
-0.62
-0.44
-1.9
EBITDA per share
0.26
-0.4
-0.46
-0.63
-0.45
-1.94
Total debt per share
—
—
—
—
—
—
Cash per share
3.99
3.69
3.35
2.8
2.61
12.44
Net current asset value per share
4.12
3.8
3.44
2.94
2.96
13.14
Tangible book value per share
3.87
3.59
3.2
2.61
2.54
11.94
Working capital per share
3.84
3.56
3.17
2.59
2.51
11.83
Book value per share
3.87
3.59
3.2
2.61
2.54
11.94
뉴스
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%
Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Lipocine completes patient visits in phase 3 trial for PPD treatment
H.C. 웨인라이트, 라이포신 목표 주가 15달러로 상향 조정
H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress
Lipocine completes enrollment in phase 3 trial for PPD treatment
리포신, 긍정적 안전성 검토 후 PPD 약물 임상 지속
Lipocine’s PPD drug trial continues after positive safety review
리포신, 산후 우울증 치료제 임상 80% 등록 완료
Lipocine reaches 80% enrollment in postpartum depression drug trial
리포신, AES 연례 회의서 LPCN 2101 간질 후보 물질 데이터 발표